Showing results (111-120 of 119) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Stem Cells and Development|July 21, 2015
CD34(+) Liver Cancer Stem Cells Were Formed by Fusion of Hepatobiliary Stem/Progenitor Cells with Hematopoietic Precursor-Derived Myeloid IntermediatesChangjun Zeng, Yanling Zhang, Su Cheol Park, et al.Stem Cell Research & Therapy|May 26, 2022
Dextran sulfate prevents excess aggregation of human pluripotent stem cells in 3D culture by inhibiting ICAM1 expression coupled with down-regulating E-cadherin through activating the Wnt signaling pathwayHaibin Wu, Xianglian Tang, Yiyu Wang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2002
Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectorsDavid Strayer, Francisco Branco, Mark A Zern, et al.Cell Proliferation|August 14, 2021
The combination of dextran sulphate and polyvinyl alcohol prevents excess aggregation and promotes proliferation of pluripotent stem cells in suspension cultureXianglian Tang, Haibin Wu, Jinghe Xie, et al.Stem Cells Translational Medicine|May 18, 2013
Highly efficient differentiation of functional hepatocytes from human induced pluripotent stem cellsXiaocui Ma, Yuyou Duan, Benjamin Tschudy-Seney, et al.Stem Cells and Development|April 14, 2015
Clonogenically Culturing and Expanding CD34+ Liver Cancer Stem Cells in VitroSu Cheol Park, Changjun Zeng, Benjamin Tschudy-Seney, et al.Stem Cells and Development|December 19, 2014
Identification of cancer stem cell subpopulations of CD34(+) PLC/PRF/5 that result in three types of human liver carcinomasSu Cheol Park, Ngoc Tue Nguyen, Jong Ryeol Eun, et al.Gastroenterology|February 12, 2009
Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1Hideki Tatsukawa, Yayoi Fukaya, Gordon Frampton, et al.Journal of Nanobiotechnology|December 21, 2021
3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFβRII-SMADS pathwayNing Wang, Xiajing Li, Zhiyong Zhong, et al.Pageof 12